INCR earnings: real EPS beat/miss history, analyst consensus Buy, P/E -4.01. Updated 2026-07-23.
InterCure (INCR) Research Hub
InterCure (INCR) trades on NASDAQ, IL in the Healthcare (Drug Manufacturers - Specialty & Generic) sector. As of 2026-09-11, shares last closed at 5.16 USD (-1.71%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -4.01, market cap 0.05B. This hub links to the full technical, earnings and options research available for INCR.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Drug Manufacturers - Specialty & Generic) |
|---|---|
| Exchange | NASDAQ, IL |
| Last close | 5.16 USD (-1.71%) |
| 52-week range | 4.24 USD – 6.1 USD |
| Trend regime | Range |
| 14-day RSI | 53.6 (Neutral) |
| Trailing P/E | -4.01 |
| Market cap | 0.05B |
| Dividend yield | 0.00% |
Available research for INCR
Covered Call on INCR: how it works, illustrative setup around the real 5.16 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on INCR: how it works, illustrative setup around the real 5.16 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on INCR: how it works, illustrative setup around the real 5.16 USD price, max profit/loss, breakeven and when to use it. Educational.
INCR technical analysis: range, last 5.16 USD, RSI 53.6, 52w range 4.24 USD–6.1 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is INCR in?
InterCure (INCR) is classified under Healthcare (Drug Manufacturers - Specialty & Generic), listed on NASDAQ, IL.
Is INCR in an uptrend or downtrend?
As of 2026-09-11, INCR is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is INCR's trailing P/E ratio?
INCR's trailing P/E is -4.01, with a market cap of 0.05B. See the earnings research page for full valuation detail.